ArticleScience advances2024

Small-molecule probe for IBD risk variant GPR65 I231L alters cytokine signaling networks through positive allosteric modulation.

Ilona Neale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.